Gene-environment interactions at the FKBP5 locus: Sensitive periods, mechanisms and pleiotropism

Genes, Brain and Behavior

Volumn 13, Issue 1, 2014, Pages 25-37

  Zannas, A S ^a,b   Binder, E B ^a,c  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Childhood abuse; FKBP5; Gene environment interactions; Glucocorticoid receptor; Major depressive disorder; Post traumatic stress disorder

Indexed keywords

FK 506 BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; MESSENGER RNA;

ANXIETY DISORDER; ARTICLE; FK 506 BINDING PROTEIN 51 GENE; GENE; GENE LOCUS; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INJURY; MENTAL DISEASE; MOOD DISORDER; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; STRESS;

CHILDHOOD ABUSE; FKBP5; GENE-ENVIRONMENT INTERACTIONS; GLUCOCORTICOID RECEPTOR; MAJOR DEPRESSIVE DISORDER; POST-TRAUMATIC STRESS DISORDER;

ANIMALS; GENE-ENVIRONMENT INTERACTION; GENETIC PLEIOTROPY; HUMANS; MENTAL DISORDERS; POLYMORPHISM, GENETIC; STRESS, PSYCHOLOGICAL; TACROLIMUS BINDING PROTEINS;

EID: 84891633163     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/gbb.12104     Document Type: Article

References (110)

1. Altomare, D.A. & Khaled, A.R. (2012) Homeostasis and the importance for a balance between AKT/mTOR activity and intracellular signaling. Curr Med Chem 19, 3748-3762.
2. Anacker, C., Zunszain, P.A., Cattaneo, A., Carvalho, L.A., Garabedian, M.J., Thuret, S., Price, J. & Pariante, C.M. (2011) Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol Psychiatry 16, 738-750.
3. Appel, K., Schwahn, C., Mahler, J., Schulz, A., Spitzer, C., Fenske, K., Stender, J., Barnow, S., John, U., Teumer, A., Biffar, R., Nauck, M., Völzke, H., Freyberger, H.J. & Grabe, H.J. (2011) Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology 36, 1982-1991.
4. Attwood, B.K., Bourgognon, J.M., Patel, S., Mucha, M., Schiavon, E., Skrzypiec, A.E., Young, K.W., Shiosaka, S., Korostynski, M., Piechota, M., Przewlocki, R. & Pawlak, R. (2011) Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature 473, 372-375.
5. Barent, R.L., Nair, S.C., Carr, D.C., Ruan, Y., Rimerman, R.A., Fulton, J., Zhang, Y. & Smith, D.F. (1998) Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes. Mol Endocrinol 12, 342-354.
6. Baughman, G., Wiederrecht, G.J., Campbell, N.F., Martin, M.M. & Bourgeois, S. (1995) FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol Cell Biol 15, 4395-4402.
7. Bertolino, E. & Singh, H. (2002) POU/TBP cooperativity: a mechanism for enhancer action from a distance. Mol Cell 10, 397-407.
8. Bevilacqua, L., Carli, V., Sarchiapone, M., George, D.K., Goldman, D., Roy, A. & Enoch, M.A. (2012) Interaction between FKBP5 and childhood trauma and risk of aggressive behavior. Arch Gen Psychiatry 69, 62-70.
9. Binder, E.B., Salyakina, D., Lichtner, P. et al. (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36, 1319-1325.
10. Binder, E.B., Bradley, R.G., Liu, W., Epstein, M.P., Deveau, T.C., Mercer, K.B., Tang, Y., Gillespie, C.F., Heim, C.M., Nemeroff, C.B., Schwartz, A.C., Cubells, J.F. & Ressler, K.J. (2008) Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299, 1291-1305.
11. Blair, L.J., Nordhues, B.A., Hill, S.E., Scaglione, K.M., O'Leary, J.C. 3rd, Fontaine, S.N., Breydo, L., Zhang, B., Li, P., Wang, L., Cotman, C., Paulson, H.L., Muschol, M., Uversky, V.N., Klengel, T., Binder, E.B., Kayed, R., Golde, T.E., Berchtold, N. & Dickey, C.A. (2013) Accelerated neurodegeneration through chaperone-mediated oligomerization of tau. J Clin Invest 123, 4158-4169.
12. Boscarino, J.A., Erlich, P.M., Hoffman, S.N. & Zhang, X. (2012) Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment. Neuropsychiatr Dis Treat 8, 131-139.
13. Bradley, R.G., Binder, E.B., Epstein, M.P., Tang, Y., Nair, H.P., Liu, W., Gillespie, C.F., Berg, T., Evces, M., Newport, D.J., Stowe, Z.N., Heim, C.M., Nemeroff, C.B., Schwartz, A., Cubells, J.F. & Ressler, K.J. (2008) Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 65, 190-200.
14. Brasier, A.R. (2010) The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86, 211-218.
15. Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A. & Poulton, R. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389.
16. Caspi, A., Hariri, A.R., Holmes, A., Uher, R. & Moffitt, T.E. (2010) Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 167, 509-527.
17. Chapman, D.P., Whitfield, C.L., Felitti, V.J., Dube, S.R., Edwards, V.J. & Anda, R.F. (2004) Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord 82, 217-225.
18. Chrousos, G.P. & Gold, P.W. (1992) The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267, 1244-1252.
19. Collip, D., Myin-Germeys, I., Wichers, M., Jacobs, N., Derom, C., Thiery, E., Lataster, T., Simons, C., Delespaul, P., Marcelis, M., van Os, J. & van Winkel, R. (2013) FKBP5 as a possible moderator of the psychosis-inducing effects of childhood trauma. Br J Psychiatry 202, 261-268.
20. Cross-Disorder Group of the Psychiatric Genomics Consortium, Smoller, J.W., Craddock, N., Kendler, K., Lee, P.H., Neale, B.M., Nurnberger, J.I., Ripke, S., Santangelo, S. & Sullivan, P.F. (2013) Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371-1379.
21. Dackis, M.N., Rogosch, F.A., Oshri, A. & Cicchetti, D. (2012) The role of limbic system irritability in linking history of childhood maltreatment and psychiatric outcomes in low-income, high-risk women: moderation by FK506 binding protein 5 haplotype. Dev Psychopathol 24, 1237-1252.
22. Danese, A., Moffitt, T.E., Harrington, H., Milne, B.J., Polanczyk, G., Pariante, C.M., Poulton, R. & Caspi, A. (2009) Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med 163, 1135-1143.
23. Davies, T.H., Ning, Y.M. & Sánchez, E.R. (2002) A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem 277, 4597-4600.
24. Duncan, L.E. & Keller, M.C. (2011) A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. Am J Psychiatry 168, 1041-1049.
25. Ellsworth, K.A., Eckloff, B.W., Li, L., Moon, I., Fridley, B.L., Jenkins, G.D., Carlson, E., Brisbin, A., Abo, R., Bamlet, W., Petersen, G., Wieben, E.D. & Wang, L. (2013a) Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. PLoS One 8, e70216.
26. Ellsworth, K.A., Moon, I., Eckloff, B.W., Fridley, B.L., Jenkins, G.D., Batzler, A., Biernacka, J.M., Abo, R., Brisbin, A., Ji, Y., Hebbring, S., Wieben, E.D., Mrazek, D.A., Weinshilboum, R.M. & Wang, L. (2013b) FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder. Pharmacogenet Genomics 23, 156-166.
27. Enoch, M.A., Hodgkinson, C.A., Yuan, Q., Shen, P.H., Goldman, D. & Roy, A. (2010) The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence. Biol Psychiatry 67, 20-27.
28. Fabian, A.K., März, A., Neimanis, S., Biondi, R.M., Kozany, C. & Hausch, F. (2013) InterAKTions with FKBPs--mutational and pharmacological exploration. PLoS One 8, e57508.
29. Fani, N., Gutman, D., Tone, E.B., Almli, L., Mercer, K.B., Davis, J., Glover, E., Jovanovic, T., Bradley, B., Dinov, I.D., Zamanyan, A., Toga, A.W., Binder, E.B. & Ressler, K.J. (2013) FKBP5 and attention bias for threat: associations with hippocampal function and shape. JAMA Psychiatry 70, 392-400.
30. Fisher, H.L., Caspi, A., Poulton, R., Meier, M.H., Houts, R., Harrington, H., Arseneault, L. & Moffitt, T.E. (2013) Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. Psychol Med 43, 2077-2086.
31. Franklin, T.B., Russig, H., Weiss, I.C., Gräff, J., Linder, N., Michalon, A., Vizi, S. & Mansuy, I.M. (2010) Epigenetic transmission of the impact of early stress across generations. Biol Psychiatry 68, 408-415.
32. Gafford, G.M., Guo, J.D., Flandreau, E.I., Hazra, R., Rainnie, D.G. & Ressler, K.J. (2012) Cell-type specific deletion of GABA(A)α1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction. Proc Natl Acad Sci U S A 109, 16330-16335.
33. Galat, A. (2013) Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands. Cell Mol Life Sci 70, 3243-3275.
34. Gallo, L.I., Ghini, A.A., Piwien Pilipuk, G. & Galigniana, M.D. (2007) Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity. Biochemistry 46, 14044-14057.
35. Grad, I. & Picard, D. (2007) The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 275, 2-12.
36. Hartmann, J., Wagner, K.V., Liebl, C., Scharf, S.H., Wang, X.D., Wolf, M., Hausch, F., Rein, T., Schmidt, U., Touma, C., Cheung-Flynn, J., Cox, M.B., Smith, D.F., Holsboer, F., Müller, M.B. & Schmidt, M.V. (2012) The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 62, 332-339.
37. Heim, C. & Binder, E.B. (2012) Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol 233, 102-111.
38. Hoffmann, A. & Spengler, D. (in press) DNA memories of early social life. Neuroscience (in press).
39. Hogg, K., Price, E.M., Hanna, C.W. & Robinson, W.P. (2012) Prenatal and perinatal environmental influences on the human fetal and placental epigenome. Clin Pharmacol Ther 92, 716-726.
40. Hubler, T.R. & Scammell, J.G. (2004) Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 9, 243-252.
41. Hubler, T.R., Denny, W.B., Valentine, D.L., Cheung-Flynn, J., Smith, D.F. & Scammell, J.G. (2003) The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. Endocrinology 144, 2380-2387.
42. Ising, M., Depping, A.M., Siebertz, A., Lucae, S., Unschuld, P.G., Kloiber, S., Horstmann, S., Uhr, M., Müller-Myhsok, B. & Holsboer, F. (2008) Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci 28, 389-398.
43. Jääskeläinen, T., Makkonen, H. & Palvimo, J.J. (2011) Steroid up-regulation of FKBP51 and its role in hormone signaling. Curr Opin Pharmacol 11, 326-331.
44. Jacobson, L. & Sapolsky, R. (1991) The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12, 118-134.
45. Karg, K., Burmeister, M., Shedden, K. & Sen, S. (2011) The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 68, 444-454.
46. Keller, M.C. (in press) Gene × environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution. Biol Psychiatry (in press).
47. Kelly, M.M., King, E.M., Rider, C.F., Gwozd, C., Holden, N.S., Eddleston, J., Zuraw, B., Leigh, R., O'Byrne, P.M. & Newton, R. (2012) Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide. Br J Pharmacol 165, 1737-1747.
48. Kendler, K.S., Karkowski, L.M. & Prescott, C.A. (1999) Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 156, 837-841.
49. Kilpatrick, D.G., Koenen, K.C., Ruggiero, K.J., Acierno, R., Galea, S., Resnick, H.S., Roitzsch, J., Boyle, J. & Gelernter, J. (2007) The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry 164, 1693-1699.
50. Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J.C., Pariante, C.M., Pace, T.W., Mercer, K.B., Mayberg, H.S., Bradley, B., Nemeroff, C.B., Holsboer, F., Heim, C.M., Ressler, K.J., Rein, T. & Binder, E.B. (2013) Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 16, 33-41.
51. de Kloet, E.R., Joëls, M. & Holsboer, F. (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6, 463-475.
52. Koenen, K.C., Aiello, A.E., Bakshis, E., Amstadter, A.B., Ruggiero, K.J., Acierno, R., Kilpatrick, D.G., Gelernter, J. & Galea, S. (2009) Modification of the association between serotonin transporter genotype and risk of posttraumatic stress disorder in adults by county-level social environment. Am J Epidemiol 169, 704-711.
53. Lahey, B.B., Applegate, B., Hakes, J.K., Zald, D.H., Hariri, A.R. & Rathouz, P.J. (2012) Is there a general factor of prevalent psychopathology during adulthood? J Abnorm Psychol 121, 971-977.
54. Lanius, R.A., Frewen, P.A., Vermetten, E. & Yehuda, R. (2010) Fear conditioning and early life vulnerabilities: two distinct pathways of emotional dysregulation and brain dysfunction in PTSD. Eur J Psychotraumatol 1. DOI: 10.3402/ejpt.v1i0.5467.
55. Lee, R.S., Tamashiro, K.L., Yang, X., Purcell, R.H., Harvey, A., Willour, V.L., Huo, Y., Rongione, M., Wand, G.S. & Potash, J.B. (2010) Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice. Endocrinology 151, 4332-4343.
56. Lee, R.S., Tamashiro, K.L., Yang, X., Purcell, R.H., Huo, Y., Rongione, M., Potash, J.B. & Wand, G.S. (2011) A measure of glucocorticoid load provided by DNA methylation of Fkbp5 in mice. Psychopharmacology (Berl) 218, 303-312.
57. Lemos, J.C., Wanat, M.J., Smith, J.S., Reyes, B.A., Hollon, N.G., Van Bockstaele, E.J., Chavkin, C. & Phillips, P.E. (2012) Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature 490, 402-406.
58. Lessard, J. & Holman, E.A. (in press) FKBP5 and CRHR1 polymorphisms moderate the stress-physical health association in a national sample. Health Psychol (in press).
59. Li, T.K., Baksh, S., Cristillo, A.D. & Bierer, B.E. (2002) Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin. J Cell Biochem 84, 460-471.
60. Li, S., Hursting, S.D., Davis, B.J., McLachlan, J.A. & Barrett, J.C. (2003) Environmental exposure, DNA methylation, and gene regulation: lessons from diethylstilbesterol-induced cancers. Ann N Y Acad Sci 983, 161-169.
61. Luijk, M.P., Velders, F.P., Tharner, A., van Ijzendoorn, M.H., Bakermans-Kranenburg, M.J., Jaddoe, V.W., Hofman, A., Verhulst, F.C. & Tiemeier, H. (2010) FKBP5 and resistant attachment predict cortisol reactivity in infants: gene-environment interaction. Psychoneuroendocrinology 35, 1454-1461.
62. Magee, J.A., Chang, L.W., Stormo, G.D. & Milbrandt, J. (2006) Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology 147, 590-598.
63. Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke, S., O'Dushlaine, C. et al. (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45, 1150-1159.
64. März, A.M., Fabian, A.K., Kozany, C., Bracher, A. & Hausch, F. (2013) Large FK506-binding proteins shape the pharmacology of rapamycin. Mol Cell Biol 33, 1357-1367.
65. McGowan, P.O., Meaney, M.J. & Szyf, M. (2008) Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res 1237, 12-24.
66. Mehta, D., Gonik, M., Klengel, T., Rex-Haffner, M., Menke, A., Rubel, J., Mercer, K.B., Pütz, B., Bradley, B., Holsboer, F., Ressler, K.J., Müller-Myhsok, B. & Binder, E.B. (2011) Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiatry 68, 901-910.
67. Menke, A., Arloth, J., Pütz, B., Weber, P., Klengel, T., Mehta, D., Gonik, M., Rex-Haffner, M., Rubel, J., Uhr, M., Lucae, S., Deussing, J.M., Müller-Myhsok, B., Holsboer, F. & Binder, E.B. (2012) Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology 37, 1455-1464.
68. Menke, A., Klengel, T., Rubel, J., Brückl, T., Pfister, H., Lucae, S., Uhr, M., Holsboer, F. & Binder, E.B. (2013a) Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression. Genes Brain Behav 12, 289-296.
69. Menke, A., Kloiber, S., Best, J., Rex-Haffner, M., Uhr, M., Holsboer, F. & Binder, E.B. (2013b) GR-mediated FKBP5 RNA induction differentially influenced by weight in major depression and healthy controls. Pharmacopsychiatry 46, A15.
70. Miller, C.A., Gavin, C.F., White, J.A., Parrish, R.R., Honasoge, A., Yancey, C.R., Rivera, I.M., Rubio, M.D., Rumbaugh, G. & Sweatt, J.D. (2010) Cortical DNA methylation maintains remote memory. Nat Neurosci 13, 664-666.
71. Munafò, M.R., Durrant, C., Lewis, G. & Flint, J. (2009) Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry 65, 211-219.
72. Nair, S.C., Rimerman, R.A., Toran, E.J., Chen, S., Prapapanich, V., Butts, R.N. & Smith, D.F. (1997) Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. Mol Cell Biol 17, 594-603.
73. Nicolaides, N.C., Galata, Z., Kino, T., Chrousos, G.P. & Charmandari, E. (2010) The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75, 1-12.
74. Paakinaho, V., Makkonen, H., Jääskeläinen, T. & Palvimo, J.J. (2010) Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions. Mol Endocrinol 24, 511-525.
75. Pelleymounter, L.L., Moon, I., Johnson, J.A., Laederach, A., Halvorsen, M., Eckloff, B., Abo, R. & Rossetti, S. (2011) A novel application of pattern recognition for accurate SNP and indel discovery from high-throughput data: targeted resequencing of the glucocorticoid receptor co-chaperone FKBP5 in a Caucasian population. Mol Genet Metab 104, 457-469.
76. Polanczyk, G., Caspi, A., Williams, B., Price, T.S., Danese, A., Sugden, K., Uher, R., Poulton, R. & Moffitt, T.E. (2009) Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. Arch Gen Psychiatry 66, 978-985.
77. Pratt, W.B. & Toft, D.O. (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18, 306-360.
78. Qi, X.R., Kamphuis, W., Wang, S., Wang, Q., Lucassen, P.J., Zhou, J.N. & Swaab, D.F. (2013) Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendocrinology 38, 863-870.
79. Refojo, D., Schweizer, M., Kuehne, C., Ehrenberg, S., Thoeringer, C., Vogl, A.M., Dedic, N., Schumacher, M., von Wolff, G., Avrabos, C., Touma, C., Engblom, D., Schütz, G., Nave, K.A., Eder, M., Wotjak, C.T., Sillaber, I., Holsboer, F., Wurst, W. & Deussing, J.M. (2011) Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 333, 1903-1907.
80. Romano, S., Mallardo, M. & Romano, M.F. (2011) FKBP51 and the NF-κB regulatory pathway in cancer. Curr Opin Pharmacol 11, 288-293.
81. Rosvall, K.A., Bergeon Burns, C.M., Barske, J., Goodson, J.L., Schlinger, B.A., Sengelaub, D.R. & Ketterson, E.D. (2012) Neural sensitivity to sex steroids predicts individual differences in aggression: implications for behavioural evolution. Proc Biol Sci 279, 3547-3555.
82. Roy, A., Gorodetsky, E., Yuan, Q., Goldman, D. & Enoch, M.A. (2010) Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 35, 1674-1683.
83. Russell, G.M., Henley, D.E., Leendertz, J., Douthwaite, J.A., Wood, S.A., Stevens, A., Woltersdorf, W.W., Peeters, B.W., Ruigt, G.S., White, A., Veldhuis, J.D. & Lightman, S.L. (2010) Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in healthy males. J Neurosci 30, 6106-6115.
84. Russo, S.J., Murrough, J.W., Han, M.H., Charney, D.S. & Nestler, E.J. (2012a) Neurobiology of resilience. Nat Neurosci 15, 1475-1484.
85. Russo, E., Citraro, R., Constanti, A. & De Sarro, G. (2012b) The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis. Mol Neurobiol 46, 662-681.
86. Sapolsky, R.M., Armanini, M.P., Packan, D.R., Sutton, S.W. & Plotsky, P.M. (1990) Glucocorticoid feedback inhibition of adrenocorticotropic hormone secretagogue release. Relationship to corticosteroid receptor occupancy in various limbic sites. Neuroendocrinology 51, 328-336.
87. Scharf, S.H., Liebl, C., Binder, E.B., Schmidt, M.V. & Müller, M.B. (2011) Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS One 6, e16883.
88. Schiene-Fischer, C. & Yu, C. (2001) Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases. FEBS Lett 495, 1-6.
89. Schmidt, M.V., Paez-Pereda, M., Holsboer, F. & Hausch, F. (2012) The prospect of FKBP51 as a drug target. ChemMedChem 7, 1351-1359.
90. Schulkin, J., Gold, P.W. & McEwen, B.S. (1998) Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology 23, 219-243.
91. Schwabe, L., Dickinson, A. & Wolf, O.T. (2011) Stress, habits, and drug addiction: a psychoneuroendocrinological perspective. Exp Clin Psychopharmacol 19, 53-63.
92. Stechschulte, L.A. & Sanchez, E.R. (2011) FKBP51-a selective modulator of glucocorticoid and androgen sensitivity. Curr Opin Pharmacol 11, 332-337.
93. Sullivan, P.F., Neale, M.C. & Kendler, K.S. (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157, 1552-1562.
94. Sullivan, P.F., Daly, M.J. & O'Donovan, M. (2012) Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 13, 537-551.
95. Telese, F., Gamliel, A., Skowronska-Krawczyk, D., Garcia-Bassets, I. & Rosenfeld, M.G. (2013) "Seq-ing" insights into the epigenetics of neuronal gene regulation. Neuron 77, 606-623.
96. Thomassin, H., Flavin, M., Espinás, M.L. & Grange, T. (2001) Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J 20, 1974-1983.
97. Touma, C., Gassen, N.C., Herrmann, L., Cheung-Flynn, J., Büll, D.R., Ionescu, I.A., Heinzmann, J.M., Knapman, A., Siebertz, A., Depping, A.M., Hartmann, J., Hausch, F., Schmidt, M.V., Holsboer, F., Ising, M., Cox, M.B., Schmidt, U. & Rein, T. (2011) FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol Psychiatry 70, 928-936.
98. Tsolaki, M., Kounti, F. & Karamavrou, S. (2009) Severe psychological stress in elderly individuals: a proposed model of neurodegeneration and its implications. Am J Alzheimers Dis Other Demen 24, 85-94.
99. U, M., Shen, L., Oshida, T., Miyauchi, J., Yamada, M. & Miyashita, T. (2004) Identification of novel direct transcriptional targets of glucocorticoid receptor. Leukemia 18, 1850-1856.
100. Velders, F.P., Kuningas, M., Kumari, M., Dekker, M.J., Uitterlinden, A.G., Kirschbaum, C., Hek, K., Hofman, A., Verhulst, F.C., Kivimaki, M., Van Duijn, C.M., Walker, B.R. & Tiemeier, H. (2011) Genetics of cortisol secretion and depressive symptoms: a candidate gene and genome wide association approach. Psychoneuroendocrinology 36, 1053-1061.
101. Vermeer, H., Hendriks-Stegeman, B.I., van der Burg, B., van Buul-Offers, S.C. & Jansen, M. (2003) Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab 88, 277-284.
102. Wang, L. (2011) FKBP51 regulation of AKT/protein kinase B phosphorylation. Curr Opin Pharmacol 11, 360-364.
103. Wang, Y., Kirschner, A., Fabian, A.K., Gopalakrishnan, R., Kress, C., Hoogeland, B., Koch, U., Kozany, C., Bracher, A. & Hausch, F. (2013) Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control. J Med Chem 56, 3922-3935.
104. Weaver, I.C., Cervoni, N., Champagne, F.A., D'Alessio, A.C., Sharma, S., Seckl, J.R., Dymov, S., Szyf, M. & Meaney, M.J. (2004) Epigenetic programming by maternal behavior. Nat Neurosci 7, 847-854.
105. White, M.G., Bogdan, R., Fisher, P.M., Muñoz, K.E., Williamson, D.E. & Hariri, A.R. (2012) FKBP5 and emotional neglect interact to predict individual differences in amygdala reactivity. Genes Brain Behav 11, 869-878.
106. van Winkel, R., Stefanis, N.C. & Myin-Germeys, I. (2008) Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 34, 1095-1105.
107. Wochnik, G.M., Ruegg, J., Abel, G.A., Schmidt, U., Holsboer, F. & Rein, T. (2005) FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 280, 4609-4616.
108. Xie, P., Kranzler, H.R., Poling, J., Stein, M.B., Anton, R.F., Farrer, L.A. & Gelernter, J. (2010) Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 35, 1684-1692.
109. Zhang, X., Clark, A.F. & Yorio, T. (2008) FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness. Invest Ophthalmol Vis Sci 49, 1037-1047.
110. Zimmermann, P., Brückl, T., Nocon, A., Pfister, H., Binder, E.B., Uhr, M., Lieb, R., Moffitt, T.E., Caspi, A., Holsboer, F. & Ising, M. (2011) Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am J Psychiatry 168, 1107-1116.